Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved]
Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clin...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2017-04-01
|
| Series: | F1000Research |
| Subjects: | |
| Online Access: | https://f1000research.com/articles/6-519/v1 |
| _version_ | 1818413277920624640 |
|---|---|
| author | Sepehr Bahadorani Michael Singer |
| author_facet | Sepehr Bahadorani Michael Singer |
| author_sort | Sepehr Bahadorani |
| collection | DOAJ |
| description | Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD. |
| first_indexed | 2024-12-14T11:00:39Z |
| format | Article |
| id | doaj.art-b3f44746b1874b0ca7d5a4252036b710 |
| institution | Directory Open Access Journal |
| issn | 2046-1402 |
| language | English |
| last_indexed | 2024-12-14T11:00:39Z |
| publishDate | 2017-04-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | F1000Research |
| spelling | doaj.art-b3f44746b1874b0ca7d5a4252036b7102022-12-21T23:04:45ZengF1000 Research LtdF1000Research2046-14022017-04-01610.12688/f1000research.10998.111857Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved]Sepehr Bahadorani0Michael Singer1University of Texas Health Science Center at San Antonio, San Antonio, TX, USAMedical Center Ophthalmology Associates, San Antonio, TX, USACurrent management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD.https://f1000research.com/articles/6-519/v1Genetics of the Immune SystemGlaucomaImmunopharmacology & Hematologic PharmacologyInnate ImmunityNeurobiology of Disease & RegenerationNeuro-Ophthalmology & Neuro-OtologyNeuropharmacology & PsychopharmacologyRetinal, Vitreous & Macular DisordersStem Cells & Regeneration |
| spellingShingle | Sepehr Bahadorani Michael Singer Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] F1000Research Genetics of the Immune System Glaucoma Immunopharmacology & Hematologic Pharmacology Innate Immunity Neurobiology of Disease & Regeneration Neuro-Ophthalmology & Neuro-Otology Neuropharmacology & Psychopharmacology Retinal, Vitreous & Macular Disorders Stem Cells & Regeneration |
| title | Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] |
| title_full | Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] |
| title_fullStr | Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] |
| title_full_unstemmed | Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] |
| title_short | Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved] |
| title_sort | recent advances in the management and understanding of macular degeneration version 1 referees 2 approved |
| topic | Genetics of the Immune System Glaucoma Immunopharmacology & Hematologic Pharmacology Innate Immunity Neurobiology of Disease & Regeneration Neuro-Ophthalmology & Neuro-Otology Neuropharmacology & Psychopharmacology Retinal, Vitreous & Macular Disorders Stem Cells & Regeneration |
| url | https://f1000research.com/articles/6-519/v1 |
| work_keys_str_mv | AT sepehrbahadorani recentadvancesinthemanagementandunderstandingofmaculardegenerationversion1referees2approved AT michaelsinger recentadvancesinthemanagementandunderstandingofmaculardegenerationversion1referees2approved |